Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority to DO2003000709ApriorityCriticalpatent/DOP2003000709A/en
Publication of DOP2003000709ApublicationCriticalpatent/DOP2003000709A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invernción se refieres a compuesto de fórmala I en la que X, Y, Z, A, R1, R2, R3, R4, R9, W1 y W2 se definen como en la memoria descritiva, a composiciones farmacéuticas que las contienen y a su uso en el tratamiento del sistema nervioso central y otros trastornos.Wintering refers to a compound of form I in which X, Y, Z, A, R1, R2, R3, R4, R9, W1 and W2 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of the central nervous system and other disorders.
DO2003000709A2003-09-102003-09-10
HETEROCICLIC PIPERAZINAS REPLACED FOR THE TREATMENT OF CHICHOPHRENIA
DOP2003000709A
(en)
DERIVATIVES OF 2,3-DIHYDROBENZO [1,4] DIOXIN-2-ILMETILO AS ALFA2C ANTAGONISTS FOR USE IN THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISEASES
Compounds derived from n-substituted piperidinyl 4-arylsulfonamides, which act as modulators of the sfrp-1 protein; process to prepare the compounds; pharmaceutical composition comprising said co-compounds and use of the compounds to prepare medicaments for the treatment of diseases.